For example, FTO reduces the m6A level of E2F1 and increases E2F1 expression in NSCLC, which facilitates cell proliferation and metastasis by activating neural epidermal growth factor-like 2 (NELL2) transcription, and thus promoting tumorigenesis 162. This evidence concerns the gene E2F1 and non-small cell lung carcinoma.